| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neoplasms, Radiation-Induced | 24 | 2020 | 79 | 4.560 |
Why?
|
| Occupational Exposure | 10 | 2018 | 122 | 1.970 |
Why?
|
| Dose-Response Relationship, Radiation | 20 | 2020 | 84 | 1.380 |
Why?
|
| Carcinogens | 25 | 2016 | 86 | 1.320 |
Why?
|
| Models, Biological | 27 | 2016 | 981 | 1.080 |
Why?
|
| Radiation Exposure | 2 | 2018 | 84 | 1.080 |
Why?
|
| Environmental Exposure | 8 | 2018 | 269 | 1.040 |
Why?
|
| Risk Assessment | 13 | 2016 | 2007 | 0.940 |
Why?
|
| Nuclear Warfare | 9 | 2008 | 11 | 0.920 |
Why?
|
| Aedes | 1 | 2022 | 5 | 0.860 |
Why?
|
| Infertility, Male | 1 | 2022 | 35 | 0.850 |
Why?
|
| Cause of Death | 4 | 2020 | 241 | 0.820 |
Why?
|
| Gamma Rays | 3 | 2017 | 64 | 0.800 |
Why?
|
| Ultraviolet Rays | 2 | 2020 | 130 | 0.790 |
Why?
|
| Radiation Dosage | 14 | 2018 | 419 | 0.780 |
Why?
|
| Leukemia, Radiation-Induced | 7 | 2007 | 9 | 0.770 |
Why?
|
| Radiation Injuries | 5 | 2017 | 97 | 0.760 |
Why?
|
| Neoplasms | 25 | 2010 | 1667 | 0.730 |
Why?
|
| Radiometry | 6 | 2017 | 64 | 0.730 |
Why?
|
| Safety-Based Drug Withdrawals | 1 | 2020 | 1 | 0.720 |
Why?
|
| Thorium | 1 | 2020 | 4 | 0.720 |
Why?
|
| Spondylitis, Ankylosing | 1 | 2020 | 10 | 0.720 |
Why?
|
| Leukemia | 2 | 2020 | 117 | 0.710 |
Why?
|
| Radium | 1 | 2020 | 12 | 0.710 |
Why?
|
| Plutonium | 2 | 2010 | 49 | 0.650 |
Why?
|
| Lung Neoplasms | 11 | 2014 | 1173 | 0.640 |
Why?
|
| Neutrons | 2 | 2017 | 5 | 0.640 |
Why?
|
| Societies, Scientific | 2 | 2016 | 18 | 0.630 |
Why?
|
| Whole-Body Irradiation | 2 | 2017 | 52 | 0.600 |
Why?
|
| Neoplasms, Experimental | 13 | 1988 | 118 | 0.580 |
Why?
|
| Inhalation Exposure | 2 | 2014 | 33 | 0.540 |
Why?
|
| United States Environmental Protection Agency | 2 | 2014 | 5 | 0.540 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 2 | 2007 | 46 | 0.540 |
Why?
|
| Curium | 3 | 2010 | 3 | 0.530 |
Why?
|
| Calcium Radioisotopes | 3 | 2010 | 4 | 0.530 |
Why?
|
| Radioactive Pollutants | 3 | 2010 | 10 | 0.520 |
Why?
|
| Animals | 57 | 2022 | 20881 | 0.520 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2007 | 110 | 0.520 |
Why?
|
| Humans | 92 | 2022 | 68618 | 0.510 |
Why?
|
| Prostatic Neoplasms | 5 | 2008 | 778 | 0.510 |
Why?
|
| Radiation, Ionizing | 5 | 2010 | 37 | 0.500 |
Why?
|
| Mammography | 3 | 2002 | 310 | 0.500 |
Why?
|
| Occupational Diseases | 4 | 2005 | 68 | 0.490 |
Why?
|
| Asbestos, Amphibole | 1 | 2014 | 2 | 0.480 |
Why?
|
| Heart Diseases | 1 | 2017 | 276 | 0.480 |
Why?
|
| Power Plants | 2 | 2007 | 6 | 0.470 |
Why?
|
| Male | 48 | 2022 | 37321 | 0.460 |
Why?
|
| Aerospace Medicine | 4 | 2003 | 22 | 0.410 |
Why?
|
| Risk | 27 | 2008 | 563 | 0.410 |
Why?
|
| Japan | 15 | 2008 | 68 | 0.400 |
Why?
|
| Air Pollutants, Radioactive | 2 | 2010 | 11 | 0.390 |
Why?
|
| Public Health | 3 | 2020 | 201 | 0.380 |
Why?
|
| Breast | 2 | 2002 | 137 | 0.370 |
Why?
|
| Dose-Response Relationship, Drug | 25 | 2000 | 1745 | 0.370 |
Why?
|
| Female | 52 | 2017 | 38074 | 0.370 |
Why?
|
| Trichloroethylene | 3 | 2009 | 41 | 0.360 |
Why?
|
| Nuclear Reactors | 1 | 2010 | 8 | 0.350 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 | 2000 | 63 | 0.350 |
Why?
|
| Breast Neoplasms | 11 | 2003 | 1536 | 0.350 |
Why?
|
| Survivors | 3 | 2015 | 256 | 0.340 |
Why?
|
| Aged | 25 | 2020 | 14862 | 0.340 |
Why?
|
| Incidence | 10 | 2009 | 1603 | 0.330 |
Why?
|
| Bone Neoplasms | 1 | 2010 | 100 | 0.330 |
Why?
|
| Vitamin K | 1 | 2008 | 14 | 0.330 |
Why?
|
| Risk Factors | 17 | 2014 | 5731 | 0.320 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2008 | 60 | 0.320 |
Why?
|
| Liver Neoplasms | 7 | 2010 | 334 | 0.310 |
Why?
|
| Caffeine | 1 | 2008 | 81 | 0.310 |
Why?
|
| Middle Aged | 28 | 2020 | 21147 | 0.310 |
Why?
|
| Fatty Acids | 1 | 2008 | 222 | 0.300 |
Why?
|
| Air Pollution, Radioactive | 1 | 2007 | 3 | 0.300 |
Why?
|
| Relative Biological Effectiveness | 3 | 2017 | 10 | 0.300 |
Why?
|
| Radiation Protection | 3 | 2017 | 71 | 0.300 |
Why?
|
| Population Dynamics | 1 | 2007 | 30 | 0.290 |
Why?
|
| Pulmonary Fibrosis | 1 | 2009 | 157 | 0.290 |
Why?
|
| Aged, 80 and over | 14 | 2020 | 4848 | 0.290 |
Why?
|
| Mice | 20 | 2017 | 8474 | 0.280 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2007 | 70 | 0.280 |
Why?
|
| Ethylene Chlorohydrin | 1 | 2006 | 3 | 0.280 |
Why?
|
| Chloral Hydrate | 1 | 2006 | 5 | 0.280 |
Why?
|
| Trichloroacetic Acid | 1 | 2006 | 6 | 0.280 |
Why?
|
| Lens, Crystalline | 2 | 2017 | 39 | 0.280 |
Why?
|
| Adult | 24 | 2020 | 21403 | 0.280 |
Why?
|
| Magnetic Fields | 2 | 2016 | 21 | 0.270 |
Why?
|
| Abnormalities, Radiation-Induced | 1 | 2005 | 4 | 0.270 |
Why?
|
| Time Factors | 15 | 2020 | 4655 | 0.260 |
Why?
|
| Survival Rate | 5 | 2017 | 1056 | 0.260 |
Why?
|
| United States | 21 | 2014 | 7367 | 0.250 |
Why?
|
| Prostate-Specific Antigen | 1 | 2006 | 138 | 0.250 |
Why?
|
| Alpha Particles | 3 | 2010 | 9 | 0.250 |
Why?
|
| Radioactive Waste | 2 | 2022 | 12 | 0.250 |
Why?
|
| Statistics as Topic | 11 | 1986 | 219 | 0.250 |
Why?
|
| Hepatocytes | 1 | 2006 | 205 | 0.240 |
Why?
|
| Mortality | 10 | 2007 | 163 | 0.240 |
Why?
|
| Benchmarking | 1 | 2005 | 91 | 0.240 |
Why?
|
| Epidemiologic Studies | 3 | 2018 | 33 | 0.240 |
Why?
|
| Cardiovascular Diseases | 2 | 2006 | 940 | 0.230 |
Why?
|
| Lung Diseases | 1 | 2005 | 175 | 0.230 |
Why?
|
| Diet | 2 | 2007 | 514 | 0.220 |
Why?
|
| Age Factors | 16 | 2003 | 1864 | 0.220 |
Why?
|
| Fusion Proteins, bcr-abl | 2 | 2000 | 37 | 0.220 |
Why?
|
| Models, Statistical | 7 | 2008 | 448 | 0.220 |
Why?
|
| Dogs | 4 | 2010 | 490 | 0.220 |
Why?
|
| Mosquito Control | 1 | 2022 | 4 | 0.220 |
Why?
|
| Mosquito Vectors | 1 | 2022 | 3 | 0.220 |
Why?
|
| Survival Analysis | 2 | 2010 | 714 | 0.210 |
Why?
|
| Population Density | 1 | 2022 | 18 | 0.210 |
Why?
|
| Aircraft | 2 | 2000 | 30 | 0.210 |
Why?
|
| Aluminum Silicates | 2 | 2014 | 23 | 0.210 |
Why?
|
| Electromagnetic Fields | 2 | 2000 | 66 | 0.200 |
Why?
|
| Toxicology | 5 | 1980 | 14 | 0.200 |
Why?
|
| Water Pollutants, Radioactive | 1 | 2022 | 29 | 0.200 |
Why?
|
| Models, Genetic | 2 | 1999 | 161 | 0.200 |
Why?
|
| Physical Examination | 1 | 2002 | 152 | 0.200 |
Why?
|
| Lung | 2 | 2007 | 849 | 0.200 |
Why?
|
| Carcinogens, Environmental | 6 | 1991 | 16 | 0.200 |
Why?
|
| Injections, Intravenous | 2 | 2020 | 215 | 0.200 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2000 | 268 | 0.190 |
Why?
|
| Radiation | 1 | 2000 | 7 | 0.180 |
Why?
|
| Beta Particles | 2 | 2010 | 7 | 0.180 |
Why?
|
| Algorithms | 2 | 2003 | 1196 | 0.180 |
Why?
|
| Mutagens | 2 | 1991 | 18 | 0.180 |
Why?
|
| Sunlight | 1 | 2020 | 59 | 0.180 |
Why?
|
| Chromosome Aberrations | 2 | 2015 | 86 | 0.180 |
Why?
|
| Radiotherapy Dosage | 1 | 2020 | 125 | 0.170 |
Why?
|
| Smoking | 7 | 2014 | 1452 | 0.170 |
Why?
|
| Carcinogenicity Tests | 3 | 2005 | 4 | 0.170 |
Why?
|
| Benzene | 2 | 1989 | 9 | 0.170 |
Why?
|
| Biological Assay | 5 | 1992 | 88 | 0.170 |
Why?
|
| Rats | 14 | 2016 | 5300 | 0.170 |
Why?
|
| Tritium | 1 | 1999 | 101 | 0.170 |
Why?
|
| Radon | 2 | 2012 | 8 | 0.170 |
Why?
|
| Pilot Projects | 2 | 2022 | 1342 | 0.170 |
Why?
|
| DNA | 5 | 1998 | 597 | 0.170 |
Why?
|
| Cosmic Radiation | 1 | 1998 | 6 | 0.160 |
Why?
|
| Cohort Studies | 6 | 2010 | 2358 | 0.160 |
Why?
|
| Research Design | 9 | 2007 | 729 | 0.160 |
Why?
|
| Computer Simulation | 5 | 2016 | 706 | 0.160 |
Why?
|
| Nitrates | 2 | 2010 | 61 | 0.160 |
Why?
|
| Child, Preschool | 7 | 2012 | 3187 | 0.150 |
Why?
|
| Reference Values | 3 | 2006 | 579 | 0.150 |
Why?
|
| Case-Control Studies | 2 | 2020 | 1553 | 0.150 |
Why?
|
| Reference Standards | 2 | 2010 | 115 | 0.150 |
Why?
|
| Melanoma | 1 | 2001 | 335 | 0.150 |
Why?
|
| Nuclear Fission | 1 | 2017 | 1 | 0.150 |
Why?
|
| Cobalt Radioisotopes | 1 | 2017 | 4 | 0.150 |
Why?
|
| Sex Factors | 9 | 2016 | 1266 | 0.140 |
Why?
|
| Skin Neoplasms | 1 | 2001 | 375 | 0.140 |
Why?
|
| Linear Models | 3 | 2007 | 521 | 0.140 |
Why?
|
| Linear Energy Transfer | 1 | 2016 | 2 | 0.140 |
Why?
|
| Cocarcinogenesis | 1 | 2016 | 4 | 0.140 |
Why?
|
| Species Specificity | 7 | 2003 | 303 | 0.140 |
Why?
|
| Cell Physiological Phenomena | 1 | 2016 | 19 | 0.140 |
Why?
|
| Formaldehyde | 1 | 2016 | 48 | 0.140 |
Why?
|
| Hematologic Neoplasms | 1 | 2016 | 37 | 0.130 |
Why?
|
| Follow-Up Studies | 3 | 2020 | 3259 | 0.130 |
Why?
|
| Stomach Neoplasms | 3 | 1992 | 64 | 0.130 |
Why?
|
| Models, Theoretical | 8 | 2008 | 384 | 0.130 |
Why?
|
| Mass Screening | 3 | 2008 | 843 | 0.130 |
Why?
|
| Guidelines as Topic | 1 | 2016 | 123 | 0.130 |
Why?
|
| Nuclear Weapons | 1 | 2015 | 1 | 0.130 |
Why?
|
| Thyroid Neoplasms | 1 | 2016 | 68 | 0.130 |
Why?
|
| Adolescent | 9 | 2010 | 8912 | 0.130 |
Why?
|
| Probability | 7 | 1981 | 245 | 0.130 |
Why?
|
| Carcinogenesis | 1 | 2016 | 124 | 0.120 |
Why?
|
| Disease Models, Animal | 4 | 2010 | 2550 | 0.120 |
Why?
|
| Cross-Sectional Studies | 3 | 2007 | 2279 | 0.120 |
Why?
|
| Ohio | 1 | 2014 | 64 | 0.120 |
Why?
|
| Mesothelioma | 1 | 2014 | 21 | 0.120 |
Why?
|
| Biometry | 4 | 1984 | 72 | 0.120 |
Why?
|
| Endpoint Determination | 1 | 2014 | 82 | 0.120 |
Why?
|
| Pain | 1 | 1997 | 472 | 0.110 |
Why?
|
| Death Certificates | 1 | 1993 | 9 | 0.110 |
Why?
|
| Agrochemicals | 1 | 1993 | 3 | 0.110 |
Why?
|
| Child | 9 | 2012 | 6405 | 0.110 |
Why?
|
| Agricultural Workers' Diseases | 1 | 1993 | 14 | 0.110 |
Why?
|
| Occupational Medicine | 2 | 1990 | 20 | 0.110 |
Why?
|
| Cytochrome P-450 Enzyme System | 2 | 1993 | 62 | 0.110 |
Why?
|
| Aviation | 2 | 2003 | 13 | 0.110 |
Why?
|
| Menopause | 2 | 2002 | 47 | 0.110 |
Why?
|
| DNA Damage | 3 | 1998 | 190 | 0.110 |
Why?
|
| Intestinal Neoplasms | 1 | 1992 | 30 | 0.100 |
Why?
|
| Solvents | 2 | 2006 | 109 | 0.100 |
Why?
|
| Mutagenicity Tests | 2 | 1988 | 5 | 0.100 |
Why?
|
| Practice Guidelines as Topic | 1 | 2017 | 772 | 0.100 |
Why?
|
| Hazardous Substances | 1 | 1992 | 8 | 0.100 |
Why?
|
| Translocation, Genetic | 3 | 2003 | 74 | 0.100 |
Why?
|
| Omeprazole | 1 | 1992 | 53 | 0.100 |
Why?
|
| Europe | 4 | 2020 | 196 | 0.100 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2016 | 2083 | 0.100 |
Why?
|
| Registries | 2 | 2010 | 733 | 0.100 |
Why?
|
| Adenine | 1 | 1991 | 46 | 0.100 |
Why?
|
| Aging | 3 | 2016 | 911 | 0.100 |
Why?
|
| Kinetics | 5 | 2006 | 1047 | 0.090 |
Why?
|
| Sample Size | 1 | 2010 | 79 | 0.090 |
Why?
|
| Hydrocarbons, Fluorinated | 1 | 2010 | 5 | 0.090 |
Why?
|
| Regression Analysis | 3 | 2008 | 737 | 0.090 |
Why?
|
| Russia | 1 | 2010 | 8 | 0.090 |
Why?
|
| Radionuclide Generators | 1 | 2010 | 6 | 0.090 |
Why?
|
| Cesium Radioisotopes | 1 | 2010 | 15 | 0.090 |
Why?
|
| Chernobyl Nuclear Accident | 1 | 2010 | 14 | 0.090 |
Why?
|
| Spirometry | 1 | 2010 | 47 | 0.090 |
Why?
|
| Longevity | 2 | 2016 | 60 | 0.090 |
Why?
|
| Reproducibility of Results | 2 | 2006 | 2077 | 0.090 |
Why?
|
| Vinyl Chloride | 3 | 1986 | 12 | 0.080 |
Why?
|
| Infant | 4 | 2007 | 2891 | 0.080 |
Why?
|
| Vinyl Compounds | 2 | 1986 | 6 | 0.080 |
Why?
|
| Guanine | 1 | 1988 | 21 | 0.080 |
Why?
|
| Mathematics | 7 | 1989 | 83 | 0.080 |
Why?
|
| Longitudinal Studies | 3 | 2010 | 1054 | 0.080 |
Why?
|
| Radiation Effects | 1 | 1987 | 2 | 0.080 |
Why?
|
| Bias | 1 | 2008 | 148 | 0.080 |
Why?
|
| Altitude | 1 | 1987 | 17 | 0.080 |
Why?
|
| Mutation | 3 | 2000 | 1213 | 0.070 |
Why?
|
| Hawaii | 1 | 2007 | 24 | 0.070 |
Why?
|
| Sulfates | 1 | 2007 | 28 | 0.070 |
Why?
|
| Particulate Matter | 1 | 2007 | 41 | 0.070 |
Why?
|
| Air Pollution | 1 | 2007 | 54 | 0.070 |
Why?
|
| Lymphoma | 4 | 2016 | 116 | 0.070 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2006 | 18 | 0.070 |
Why?
|
| Air Pollutants | 1 | 2007 | 75 | 0.070 |
Why?
|
| Water Pollutants, Chemical | 2 | 2009 | 328 | 0.070 |
Why?
|
| Income | 1 | 2007 | 167 | 0.070 |
Why?
|
| Alcohol Dehydrogenase | 1 | 2006 | 32 | 0.070 |
Why?
|
| South Carolina | 2 | 2005 | 2752 | 0.070 |
Why?
|
| Body Weight | 3 | 2002 | 554 | 0.070 |
Why?
|
| Poverty | 1 | 2007 | 219 | 0.070 |
Why?
|
| National Institutes of Health (U.S.) | 3 | 1993 | 109 | 0.070 |
Why?
|
| Urban Population | 1 | 2007 | 255 | 0.070 |
Why?
|
| Cryopreservation | 1 | 2006 | 103 | 0.070 |
Why?
|
| Infant, Newborn | 2 | 2007 | 2455 | 0.060 |
Why?
|
| Anthropometry | 1 | 2005 | 64 | 0.060 |
Why?
|
| No-Observed-Adverse-Effect Level | 1 | 2005 | 5 | 0.060 |
Why?
|
| In Vitro Techniques | 1 | 2006 | 765 | 0.060 |
Why?
|
| Sex Characteristics | 1 | 2007 | 295 | 0.060 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 1984 | 137 | 0.060 |
Why?
|
| Genotype | 1 | 2006 | 786 | 0.060 |
Why?
|
| Environmental Pollution | 1 | 1983 | 25 | 0.060 |
Why?
|
| Bayes Theorem | 2 | 2008 | 307 | 0.060 |
Why?
|
| Epidemiologic Methods | 5 | 1990 | 83 | 0.060 |
Why?
|
| Adenocarcinoma | 1 | 2006 | 475 | 0.060 |
Why?
|
| Menarche | 1 | 1983 | 18 | 0.060 |
Why?
|
| Body Burden | 1 | 2003 | 27 | 0.060 |
Why?
|
| Radiation Injuries, Experimental | 1 | 2003 | 22 | 0.060 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2003 | 38 | 0.060 |
Why?
|
| Parity | 1 | 1983 | 71 | 0.060 |
Why?
|
| Maximum Allowable Concentration | 4 | 1990 | 5 | 0.050 |
Why?
|
| Breast Self-Examination | 1 | 2002 | 4 | 0.050 |
Why?
|
| Receptors, Drug | 2 | 1993 | 31 | 0.050 |
Why?
|
| Women's Health | 1 | 2003 | 148 | 0.050 |
Why?
|
| Radiobiology | 1 | 2022 | 2 | 0.050 |
Why?
|
| Models, Animal | 1 | 2003 | 252 | 0.050 |
Why?
|
| Environmental Monitoring | 1 | 2003 | 180 | 0.050 |
Why?
|
| Rivers | 1 | 2022 | 43 | 0.050 |
Why?
|
| Rats, Inbred F344 | 2 | 1994 | 104 | 0.050 |
Why?
|
| Nonlinear Dynamics | 2 | 1998 | 55 | 0.050 |
Why?
|
| Coronary Artery Disease | 1 | 1987 | 696 | 0.050 |
Why?
|
| Cell Division | 2 | 1974 | 541 | 0.050 |
Why?
|
| Educational Status | 1 | 2002 | 273 | 0.050 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 1983 | 235 | 0.050 |
Why?
|
| Insurance, Health | 1 | 2002 | 201 | 0.050 |
Why?
|
| DNA Repair | 3 | 1998 | 127 | 0.050 |
Why?
|
| Genes, abl | 1 | 2000 | 4 | 0.050 |
Why?
|
| Canada | 1 | 2001 | 267 | 0.050 |
Why?
|
| Sunburn | 1 | 2020 | 6 | 0.050 |
Why?
|
| Introns | 1 | 2000 | 68 | 0.050 |
Why?
|
| Philadelphia Chromosome | 1 | 1999 | 7 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 1999 | 23 | 0.040 |
Why?
|
| Data Collection | 1 | 2001 | 420 | 0.040 |
Why?
|
| Genetics | 1 | 1979 | 6 | 0.040 |
Why?
|
| Lymphocytes | 1 | 2000 | 228 | 0.040 |
Why?
|
| Germany | 1 | 1999 | 67 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2003 | 1753 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2003 | 931 | 0.040 |
Why?
|
| Socioeconomic Factors | 1 | 2002 | 955 | 0.040 |
Why?
|
| Likelihood Functions | 2 | 2008 | 106 | 0.040 |
Why?
|
| Animals, Laboratory | 1 | 1979 | 21 | 0.040 |
Why?
|
| Surveys and Questionnaires | 1 | 2007 | 2800 | 0.040 |
Why?
|
| Young Adult | 1 | 2010 | 5717 | 0.040 |
Why?
|
| Chromosome Breakage | 1 | 1998 | 6 | 0.040 |
Why?
|
| Attitude to Health | 1 | 2001 | 403 | 0.040 |
Why?
|
| Confidence Intervals | 1 | 1998 | 242 | 0.040 |
Why?
|
| Body Mass Index | 1 | 2002 | 867 | 0.040 |
Why?
|
| Enzyme Induction | 3 | 1993 | 119 | 0.040 |
Why?
|
| Organic Chemicals | 1 | 1998 | 77 | 0.040 |
Why?
|
| Rats, Inbred Strains | 2 | 1989 | 532 | 0.040 |
Why?
|
| Cell Survival | 1 | 2000 | 901 | 0.040 |
Why?
|
| History, 18th Century | 1 | 1997 | 26 | 0.040 |
Why?
|
| History, Ancient | 1 | 1997 | 25 | 0.040 |
Why?
|
| Vitamin D Deficiency | 1 | 2020 | 292 | 0.040 |
Why?
|
| Markov Chains | 1 | 1998 | 133 | 0.040 |
Why?
|
| History, 19th Century | 1 | 1997 | 95 | 0.040 |
Why?
|
| Life Style | 2 | 1992 | 338 | 0.030 |
Why?
|
| History, 20th Century | 1 | 1997 | 248 | 0.030 |
Why?
|
| Brain Neoplasms | 2 | 1991 | 371 | 0.030 |
Why?
|
| Odds Ratio | 1 | 1998 | 880 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2016 | 65 | 0.030 |
Why?
|
| Analgesics | 1 | 1997 | 118 | 0.030 |
Why?
|
| Vitamin D | 1 | 2020 | 516 | 0.030 |
Why?
|
| Cataract | 1 | 2017 | 134 | 0.030 |
Why?
|
| Receptors, Aryl Hydrocarbon | 2 | 1993 | 46 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2016 | 536 | 0.030 |
Why?
|
| Drug Tolerance | 2 | 1985 | 80 | 0.030 |
Why?
|
| Scleroderma, Systemic | 1 | 1998 | 446 | 0.030 |
Why?
|
| 2-Acetylaminofluorene | 2 | 1983 | 3 | 0.030 |
Why?
|
| Xenobiotics | 1 | 1993 | 17 | 0.030 |
Why?
|
| Mice, Inbred Strains | 2 | 1986 | 181 | 0.030 |
Why?
|
| Documentation | 1 | 1993 | 83 | 0.030 |
Why?
|
| Polychlorinated Dibenzodioxins | 1 | 1993 | 38 | 0.030 |
Why?
|
| Kyrgyzstan | 1 | 2012 | 1 | 0.030 |
Why?
|
| Kazakhstan | 1 | 2012 | 4 | 0.030 |
Why?
|
| Methylation | 2 | 1991 | 56 | 0.030 |
Why?
|
| Estrogens | 1 | 1993 | 173 | 0.030 |
Why?
|
| Hematologic Diseases | 1 | 1992 | 20 | 0.030 |
Why?
|
| Population Surveillance | 1 | 1994 | 285 | 0.030 |
Why?
|
| Life Expectancy | 1 | 1992 | 51 | 0.030 |
Why?
|
| Diethylnitrosamine | 1 | 1991 | 10 | 0.030 |
Why?
|
| Asia | 1 | 1992 | 59 | 0.030 |
Why?
|
| Radiation Monitoring | 1 | 2012 | 41 | 0.020 |
Why?
|
| Causality | 1 | 1992 | 82 | 0.020 |
Why?
|
| Diagnostic Errors | 1 | 1992 | 100 | 0.020 |
Why?
|
| Cricetinae | 2 | 1986 | 262 | 0.020 |
Why?
|
| Dimethylnitrosamine | 1 | 1991 | 22 | 0.020 |
Why?
|
| Health Status Indicators | 1 | 1992 | 117 | 0.020 |
Why?
|
| Research Support as Topic | 1 | 1991 | 58 | 0.020 |
Why?
|
| Tyrosine Transaminase | 1 | 1970 | 1 | 0.020 |
Why?
|
| Multicenter Studies as Topic | 1 | 1991 | 186 | 0.020 |
Why?
|
| Industry | 1 | 1991 | 28 | 0.020 |
Why?
|
| Forecasting | 1 | 1992 | 277 | 0.020 |
Why?
|
| Autoradiography | 1 | 2010 | 94 | 0.020 |
Why?
|
| Ukraine | 1 | 2010 | 13 | 0.020 |
Why?
|
| Mice, Inbred CBA | 1 | 2010 | 107 | 0.020 |
Why?
|
| Prospective Studies | 2 | 2010 | 3705 | 0.020 |
Why?
|
| Uterine Neoplasms | 1 | 2010 | 99 | 0.020 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2010 | 44 | 0.020 |
Why?
|
| Soil Pollutants, Radioactive | 1 | 2010 | 30 | 0.020 |
Why?
|
| Lung Injury | 1 | 2010 | 38 | 0.020 |
Why?
|
| Decision Making | 1 | 1993 | 410 | 0.020 |
Why?
|
| Sarcoma | 1 | 2010 | 70 | 0.020 |
Why?
|
| Airway Obstruction | 1 | 2010 | 49 | 0.020 |
Why?
|
| DDT | 2 | 1979 | 19 | 0.020 |
Why?
|
| Hydrocortisone | 1 | 1970 | 291 | 0.020 |
Why?
|
| Databases, Factual | 1 | 1992 | 622 | 0.020 |
Why?
|
| Chemistry, Physical | 1 | 1988 | 21 | 0.020 |
Why?
|
| Alkylation | 1 | 1988 | 26 | 0.020 |
Why?
|
| Chemical Phenomena | 1 | 1988 | 62 | 0.020 |
Why?
|
| Hyperplasia | 1 | 1988 | 89 | 0.020 |
Why?
|
| Salmonella | 1 | 1988 | 20 | 0.020 |
Why?
|
| Radioactive Fallout | 1 | 2008 | 3 | 0.020 |
Why?
|
| Hydrogen Bonding | 1 | 1988 | 67 | 0.020 |
Why?
|
| Carcinoma | 1 | 2010 | 215 | 0.020 |
Why?
|
| Molecular Conformation | 1 | 1988 | 128 | 0.020 |
Why?
|
| Calibration | 1 | 2008 | 73 | 0.020 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 1970 | 163 | 0.020 |
Why?
|
| Precancerous Conditions | 1 | 1988 | 74 | 0.020 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 2 | 1998 | 23 | 0.020 |
Why?
|
| Administration, Oral | 1 | 1989 | 411 | 0.020 |
Why?
|
| Background Radiation | 1 | 1987 | 4 | 0.020 |
Why?
|
| Thermodynamics | 1 | 1988 | 162 | 0.020 |
Why?
|
| Monte Carlo Method | 1 | 2008 | 124 | 0.020 |
Why?
|
| Atmosphere Exposure Chambers | 1 | 2007 | 4 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 1988 | 420 | 0.020 |
Why?
|
| Insulin | 1 | 1970 | 619 | 0.020 |
Why?
|
| Air | 1 | 2007 | 22 | 0.020 |
Why?
|
| Aerosols | 1 | 2007 | 42 | 0.020 |
Why?
|
| Liver | 2 | 1993 | 1118 | 0.020 |
Why?
|
| Base Sequence | 1 | 1988 | 1015 | 0.020 |
Why?
|
| Particle Size | 1 | 2007 | 201 | 0.020 |
Why?
|
| Colorectal Neoplasms | 1 | 1992 | 561 | 0.020 |
Why?
|
| Mesocricetus | 1 | 1986 | 32 | 0.020 |
Why?
|
| Environmental Pollutants | 1 | 1988 | 180 | 0.020 |
Why?
|
| Actuarial Analysis | 1 | 1986 | 23 | 0.020 |
Why?
|
| Lethal Dose 50 | 1 | 1985 | 13 | 0.020 |
Why?
|
| Metaphase | 1 | 2003 | 12 | 0.010 |
Why?
|
| Blood Cells | 1 | 2003 | 27 | 0.010 |
Why?
|
| Neoplasms, Hormone-Dependent | 1 | 1983 | 15 | 0.010 |
Why?
|
| Safety | 1 | 1983 | 145 | 0.010 |
Why?
|
| Postmenopause | 1 | 2003 | 93 | 0.010 |
Why?
|
| DNA, Neoplasm | 1 | 1983 | 95 | 0.010 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 1983 | 138 | 0.010 |
Why?
|
| Venous Thrombosis | 1 | 2003 | 125 | 0.010 |
Why?
|
| Coronary Disease | 1 | 2003 | 358 | 0.010 |
Why?
|
| Patient Compliance | 1 | 2003 | 402 | 0.010 |
Why?
|
| Germany, West | 2 | 1990 | 3 | 0.010 |
Why?
|
| Wales | 2 | 1990 | 3 | 0.010 |
Why?
|
| France | 2 | 1990 | 26 | 0.010 |
Why?
|
| Italy | 2 | 1990 | 36 | 0.010 |
Why?
|
| England | 2 | 1990 | 64 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1979 | 219 | 0.010 |
Why?
|
| Multiple Myeloma | 2 | 1990 | 92 | 0.010 |
Why?
|
| Cohort Effect | 1 | 1999 | 5 | 0.010 |
Why?
|
| Chloroform | 1 | 1979 | 3 | 0.010 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 1979 | 38 | 0.010 |
Why?
|
| Sentinel Surveillance | 1 | 1999 | 20 | 0.010 |
Why?
|
| Water Pollutants | 1 | 1979 | 31 | 0.010 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 1999 | 36 | 0.010 |
Why?
|
| Water Supply | 1 | 1979 | 54 | 0.010 |
Why?
|
| DNA Topoisomerases, Type I | 1 | 1998 | 13 | 0.010 |
Why?
|
| Ethidium | 1 | 1998 | 4 | 0.010 |
Why?
|
| Numerical Analysis, Computer-Assisted | 1 | 1998 | 13 | 0.010 |
Why?
|
| Fourier Analysis | 1 | 1998 | 31 | 0.010 |
Why?
|
| Indicators and Reagents | 1 | 1998 | 63 | 0.010 |
Why?
|
| Karyotyping | 1 | 1998 | 74 | 0.010 |
Why?
|
| Sex Distribution | 1 | 1999 | 274 | 0.010 |
Why?
|
| Age Distribution | 1 | 1999 | 320 | 0.010 |
Why?
|
| X-Rays | 1 | 1998 | 56 | 0.010 |
Why?
|
| Pregnancy | 1 | 1983 | 2334 | 0.010 |
Why?
|
| Antibodies | 1 | 1998 | 241 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 1998 | 271 | 0.010 |
Why?
|
| Haplorhini | 1 | 1975 | 44 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 1993 | 164 | 0.010 |
Why?
|
| Germ-Free Life | 1 | 1972 | 12 | 0.010 |
Why?
|
| Thymus Neoplasms | 1 | 1972 | 17 | 0.010 |
Why?
|
| Autopsy | 1 | 1972 | 56 | 0.010 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 1972 | 47 | 0.010 |
Why?
|
| Factor Analysis, Statistical | 1 | 1972 | 201 | 0.010 |
Why?
|
| Ligands | 1 | 1993 | 317 | 0.010 |
Why?
|
| ErbB Receptors | 1 | 1993 | 239 | 0.010 |
Why?
|
| Computers | 1 | 1971 | 63 | 0.010 |
Why?
|
| Dactinomycin | 1 | 1970 | 31 | 0.010 |
Why?
|
| Metabolism | 1 | 1970 | 12 | 0.010 |
Why?
|
| Culture Techniques | 1 | 1970 | 65 | 0.010 |
Why?
|
| Stroke | 1 | 2003 | 2163 | 0.010 |
Why?
|
| Cultural Characteristics | 1 | 1990 | 42 | 0.010 |
Why?
|
| Urologic Neoplasms | 1 | 1990 | 14 | 0.010 |
Why?
|
| Spinal Cord Neoplasms | 1 | 1990 | 24 | 0.010 |
Why?
|
| Radiography | 1 | 1990 | 572 | 0.010 |
Why?
|
| Escherichia coli | 1 | 1971 | 368 | 0.010 |
Why?
|
| Cell Line | 1 | 1970 | 1752 | 0.000 |
Why?
|
| RNA, Messenger | 1 | 1970 | 1664 | 0.000 |
Why?
|
| Communicable Diseases | 1 | 1982 | 50 | 0.000 |
Why?
|
| Nitrilotriacetic Acid | 1 | 1981 | 1 | 0.000 |
Why?
|
| Aflatoxin B1 | 1 | 1981 | 5 | 0.000 |
Why?
|
| Aflatoxins | 1 | 1981 | 6 | 0.000 |
Why?
|
| Tuberculosis | 1 | 1982 | 77 | 0.000 |
Why?
|
| Demography | 1 | 1982 | 279 | 0.000 |
Why?
|